Investor Overview

VYNE Therapeutics® is a biopharmaceutical company.

Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.

NASDAQ-GS: VYNE

1.01

Jun. 03, 2025 12:39:18
  • Change 0.0783 (8.4375%)
  • Volume 133,135
  • Today's Open 0.92
  • Previous Close 0.928
  • Today's High 1.01
  • Today's Low 0.95
  • 52 Week High 4.3
  • 52 Week Low 0.9099